Infusion and access devices for preclinical research.
AVABIO has designed and manufactured preclinical infusion and access devices since 2005, serving research customers around the world.
Chicago, Illinois
We build where research and care meet: owning and growing device businesses that serve preclinical science and veterinary medicine, and advising programs moving from bench to clinic.
FYS Holdings shapes the strategic direction and growth of its portfolio, while each operating company brings specialized expertise to the markets it serves.
Our approach connects product innovation with commercial opportunity, developing businesses around technologies that address specific needs in research and care.
A development partner at every stage of medical and life science products.
FYS Holdings works alongside companies bringing medical and life science products to market, from early concept through design, regulatory strategy, preclinical testing, and commercial launch. The work draws on the same expertise that shapes our own operating businesses.
Current engagement: development consulting for a premarket implantable infusion pump intended to treat human disease. The scope covers device development, the regulatory process, preclinical testing, and marketing.
FYS Holdings is actively seeking to acquire or partner with businesses whose products and capabilities complement its development work and operating companies.
Two operating companies, each with its own expertise and market, owned and grown by FYS Holdings.
AVABIO has designed and manufactured preclinical infusion and access devices since 2005, serving research customers around the world.
InfusiVet develops ports, catheters, and access technologies designed for veterinary medicine and the clinicians who practice it.
For partnerships, acquisition opportunities, and business inquiries: